HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of MECP2 Deficiency and Is a Potential Therapy for Rett Syndrome.

AuthorsKay-Marie Joan Lamar, Gemma L Carvill
JournalEpilepsy currents (Epilepsy Curr) 2020 Nov-Dec Vol. 20 Issue 6 Pg. 390-392 ISSN: 1535-7597 [Print] United States
PMID34025262 (Publication Type: Journal Article, Comment)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: